Latest articles and price-sensitive announcements with AI sentiment classification.
Highlights Liontown Resources is gaining attention as lithium sentiment improves across the ASX resources space. Kathleen Valley remains central to the company’s shift from developer to producer. The lithium rebound is keeping the spotlight on operational delivery and cost control. Liontown Resources is back in focus as lithium sentiment improves, with Kathleen Valley’s ramp-up shaping the c...
Is Liontown (ASX:LTR) Undervalued Following Its First Spodumene Shipment And Positive Cash Flow? simplywall.st
Liontown (ASX:LTR) Shares on Investor’s Radar – Here’s Why Kalkine
Ethics approval has cleared the way for a clinical study evaluating OROFLOW as a potential treatment for oesophageal motility disorders. ... Read More The post LTR Pharma goes with the OROFLOW in ethics-approved clinical study appeared first on Stockhead.
Highlights Liontown Resources is scaling up production at its Kathleen Valley lithium operation in Western Australia. A new Canmax offtake agreement strengthens long-term demand visibility during the mine’s transition phase. The shift from open-pit to underground mining adds both operational complexity and extended mine-life potential. Liontown Resources (ASX:LTR) is ramping Kathleen Valley production, securing a Canmax offtake and transitioning to underground mining as it builds ...
Liontown Resources (ASX:LTR): Can This Lithium Stock Regain Its Spark? Kalkine
Highlights Liontown Resources shares have attracted attention as lithium market sentiment improves. Kathleen Valley continues progressing as the company advances its transition into production. Strategic agreements with global battery and electric vehicle supply chain participants strengthen market visibility. Liontown Resources is drawing attention as Kathleen Valley advances toward stronger production activity, supported by improving lithium sentiment, resource quality and established...
Liontown shares are down 30% from a three-year high in May. The post Liontown shares crash 18% in a month: What happened? appeared first on The Motley Fool Australia.
Highlights Capacity decisions after lithium price repair are becoming a key filter for market participants assessing the sector. Liontown Resources (ASX:LTR), Mineral Resources (ASX:MIN) and IGO (ASX:IGO) are highlighting different pathways through the evolving lithium cycle. EOFY portfolio positioning, commodity volatility and company-specific execution are increasing the focus on selectivity. Australia’s share market enters the new week under a cautious backdrop, with oil prices...
Liontown Resources (ASX:LTR) Is Attracting Market Attention Today – Here’s Why Kalkine
Highlights Liontown Resources (ASX:LTR) is ramping up production at its flagship Kathleen Valley lithium operation. Strong sales volumes and cash position highlight progress in the transition from developer to producer. Long-term agreements with global battery and EV players continue to support demand visibility. Liontown Resources is ramping up production at Kathleen Valley, with strong sales execution, cash support, and global off-take agreements driving its transition into a major li...
Liontown Resources (ASX:LTR): Lithium Stock Draws Fresh Chart Watchers as Battery Metals Sentiment Swings Kalkine
Highlights A recent spodumene pricing event has renewed attention across the lithium sector. Market participants are closely monitoring supply discipline and inventory trends for signs of rebalancing. Spodumene prices remain one of the most important indicators for Australia's lithium industry. Renewed strength in spodumene pricing has sparked fresh interest in Australia's lithium industry as investors assess whether market conditions are beginning to rebalance. After a prolonged period of we...
Liontown (ASX:LTR) Shares Valuation Check After Lithium Sentiment Driven Price Move simplywall.st
Highlights Liontown Resources (ASX:LTR) experienced elevated trading activity as lithium sentiment shifted across global markets. Progress at the Kathleen Valley project remains a central focus as production ramp-up continues. Lithium pricing dynamics and cost pressures remain key themes influencing sector positioning. Liontown Resources (ASX:LTR) saw increased trading activity as lithium sentiment shifted, with Kathleen Valley development progress and market volatility shaping sector-w...
How Surging Lithium-Sentiment Trading At Liontown (ASX:LTR) Has Changed Its Investment Story simplywall.st
LTP said Strive Pharmacy becomes the exclusive US pharmacy ‘fulfilment partner’ for Roxus, providing the infrastructure to supply the treatment ... Read More The post LTR Pharma firms up exclusive US partner for its erectile dysfunction treatment appeared first on Stockhead.
LTR Pharma locks in its first commercial agreement in the US for ROXUS, opening the door to the world's largest ED ... Read More The post Break it Down: LTR secures first US commercial deal for ROXUS appeared first on Stockhead.
Why Liontown (ASX:LTR) Shares Are Under Press Today? Kalkine
Should Liontown Resources (ASX:LTR) Be on Your Lithium Watchlist? Kalkine
Broker Says “Buy” on Liontown (ASX:LTR) – Here’s Why Kalkine
Highlights Self-funded shift marks a major operational milestone China demand fuels lithium market revival Underground transition supports long-term output goals Liontown Resources advances into a self-funded phase while strengthening its lithium operations, supported by rising demand trends and strategic project optimisation. Liontown’s Self-Funded Leap Signals Lithium Strength Liontown Resources (ASX:LTR) has entered a new phase of growth, marking a key milestone as it transitio...
other announcement
Liontown (ASX:LTR) Is Up 17.9% After First Positive Net Cash Flow And Big Capex Plan – Has The Bull Case Changed? simplywall.st
Liontown (ASX:LTR) Valuation Check After Record Quarter And Shift To Underground Operations simplywall.st
We Think LTR Pharma (ASX:LTP) Can Afford To Drive Business Growth simplywall.st
Highlights SPONTAN data shows rapid onset profile Dual US regulatory pathway outlined Strong funding supports near-term milestones LTR Pharma advances its intranasal therapy with encouraging clinical data and a clear US expansion roadmap, backed by solid funding and growing real-world validation. LTR Pharma Strengthens Position with SPONTAN Progress LTR Pharma (ASX:LTP) has drawn attention following the release of encouraging interim clinical data for its SPONTAN therapy, alongside a cl...
LTR Pharma receives positive SPONTAN Phase II data ... Read More The post LTR Pharma’s SPONTAN ED nasal spray delivers rapid onset as Phase II data supports broad use appeared first on Stockhead.
other announcement
Liontown starts early works on its Kathleen Valley project, committing up to $77 million before the final investment decision. The post Liontown shares: Expansion works begin at Kathleen Valley appeared first on The Motley Fool Australia.
other announcement
Liontown Shares (ASX:LTR) Hit Multi-Year High on Breakout Rally thebull.com.au
Highlights Revenue growth reflects operational ramp-up Losses widen amid expansion phase Market focus shifts to cost control Liontown’s latest update highlights strong revenue momentum alongside rising losses, bringing attention to cost management, funding outlook, and execution strength during its lithium expansion journey. Understanding Liontown’s Latest Financial Shift (LTR) Liontown Limited (ASX:LTR) has recently delivered a financial update that reflects both progress a...
Highlights Strong revenue expansion alongside widening losses Lithium project ramp-up intensifies cost pressures Market attention centers on operational scaling dynamics Liontown developments within the ASX 200 show strong lithium sales growth paired with increased costs, reflecting project expansion and shifting dynamics across the broader resource market. Liontown Limited operates within the lithium mining and battery materials sector, supplying resources essential to energy storage and ele...
Liontown (ASX:LTR) Is Down 8.2% After Surging Revenue But Deepening Half-Year Losses - What's Changed simplywall.st
Highlights Revenue expansion draws market attention Rising loss keeps profitability debate alive Valuation views remain sharply divided Liontown’s latest update reflects strong revenue traction alongside continued losses, leaving valuation perspectives split between growth optimism and cautious cash flow outlook. The latest update from Liontown Resources Limited (ASX:LTR) has sparked renewed discussion across the mining and lithium sector, particularly among those tracking develop...
A Look At Liontown (ASX:LTR) Valuation After Half Year Revenue Growth And Wider Net Loss simplywall.st
Liontown (ASX:LTR) Valuation Check As Underground Shift And Expansion Plans Offset Wider Half Year Loss simplywall.st
Let's see what this lithium miner reported today. The post Liontown shares drop on $184m half-year loss appeared first on The Motley Fool Australia.
LTR Pharma is poised to progress the Phase II clinical study for its SPONTAN rapid-acting intranasal spray for the treatment ... Read More The post LTR Pharma takes SPONTAN Phase II study to its climax after completing recruitment appeared first on Stockhead.
Kalkine
Google News
Stockhead
ASX
Motley Fool
Small Caps